uniQure Researchers Swap Out Lead Drug for a Better Prospect Post author:Sam Post published:October 18, 2017 Post category:BioPharma The company plans to expeditiously advance AMT-061 instead of AMT-060. Source: BioSpace You Might Also Like What You Need to Know About Fibrocor Therapeutics January 25, 2018 Bio-Tissue Announces Strategic Agreement With To Promote Its Regenerative Healing Technology In Canada October 3, 2017 And He's Back! Medivation's to Helm Axovant April 9, 2017
Bio-Tissue Announces Strategic Agreement With To Promote Its Regenerative Healing Technology In Canada October 3, 2017
